369 related articles for article (PubMed ID: 16290173)
21. New chemical tools to probe cell wall biosynthesis in bacteria.
Gale RT; Brown ED
Curr Opin Microbiol; 2015 Oct; 27():69-77. PubMed ID: 26291270
[TBL] [Abstract][Full Text] [Related]
22. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
Lu H; Tonge PJ
Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
[TBL] [Abstract][Full Text] [Related]
23. In vitro reconstitution of two essential steps in wall teichoic acid biosynthesis.
Ginsberg C; Zhang YH; Yuan Y; Walker S
ACS Chem Biol; 2006 Feb; 1(1):25-8. PubMed ID: 17163636
[TBL] [Abstract][Full Text] [Related]
24. Bacterial fatty acid biosynthesis: targets for antibacterial drug discovery.
Campbell JW; Cronan JE
Annu Rev Microbiol; 2001; 55():305-32. PubMed ID: 11544358
[TBL] [Abstract][Full Text] [Related]
25. Novel targets for the future development of antibacterial agents.
McDevitt D; Payne DJ; Holmes DJ; Rosenberg M
Symp Ser Soc Appl Microbiol; 2002; (31):28S-34S. PubMed ID: 12481826
[TBL] [Abstract][Full Text] [Related]
26. Development of novel inhibitors targeting intracellular steps of peptidoglycan biosynthesis.
Kotnik M; Anderluh PS; Prezelj A
Curr Pharm Des; 2007; 13(22):2283-309. PubMed ID: 17692001
[TBL] [Abstract][Full Text] [Related]
27. Small molecule inhibitors of peptidoglycan synthesis targeting the lipid II precursor.
Derouaux A; Turk S; Olrichs NK; Gobec S; Breukink E; Amoroso A; Offant J; Bostock J; Mariner K; Chopra I; Vernet T; Zervosen A; Joris B; Frère JM; Nguyen-Distèche M; Terrak M
Biochem Pharmacol; 2011 May; 81(9):1098-105. PubMed ID: 21356201
[TBL] [Abstract][Full Text] [Related]
28. New generation of peptide antibiotics.
Dubin A; Mak P; Dubin G; Rzychon M; Stec-Niemczyk J; Wladyka B; Maziarka K; Chmiel D
Acta Biochim Pol; 2005; 52(3):633-8. PubMed ID: 16175238
[TBL] [Abstract][Full Text] [Related]
29. Highly sensitive target-based whole-cell antibacterial discovery strategy by antisense RNA silencing.
Singh SB; Phillips JW; Wang J
Curr Opin Drug Discov Devel; 2007 Mar; 10(2):160-6. PubMed ID: 17436551
[TBL] [Abstract][Full Text] [Related]
30. The bacterial cell wall as a source of antibacterial targets.
Green DW
Expert Opin Ther Targets; 2002 Feb; 6(1):1-19. PubMed ID: 11901475
[TBL] [Abstract][Full Text] [Related]
31. Use of genomics to select antibacterial targets.
Pucci MJ
Biochem Pharmacol; 2006 Mar; 71(7):1066-72. PubMed ID: 16412986
[TBL] [Abstract][Full Text] [Related]
32. Breaking down the cell wall: Strategies for antibiotic discovery targeting bacterial transpeptidases.
Cochrane SA; Lohans CT
Eur J Med Chem; 2020 May; 194():112262. PubMed ID: 32248005
[TBL] [Abstract][Full Text] [Related]
33. The folic acid biosynthesis pathway in bacteria: evaluation of potential for antibacterial drug discovery.
Bermingham A; Derrick JP
Bioessays; 2002 Jul; 24(7):637-48. PubMed ID: 12111724
[TBL] [Abstract][Full Text] [Related]
34. Naphthyl tetronic acids as multi-target inhibitors of bacterial peptidoglycan biosynthesis.
Mansour TS; Caufield CE; Rasmussen B; Chopra R; Krishnamurthy G; Morris KM; Svenson K; Bard J; Smeltzer C; Naughton S; Antane S; Yang Y; Severin A; Quagliato D; Petersen PJ; Singh G
ChemMedChem; 2007 Oct; 2(10):1414-7. PubMed ID: 17600795
[No Abstract] [Full Text] [Related]
35. Inhibitors targeting on cell wall biosynthesis pathway of MRSA.
Hao H; Cheng G; Dai M; Wu Q; Yuan Z
Mol Biosyst; 2012 Nov; 8(11):2828-38. PubMed ID: 22898792
[TBL] [Abstract][Full Text] [Related]
36. Intracellular steps of bacterial cell wall peptidoglycan biosynthesis: enzymology, antibiotics, and antibiotic resistance.
Bugg TD; Walsh CT
Nat Prod Rep; 1992 Jun; 9(3):199-215. PubMed ID: 1436736
[No Abstract] [Full Text] [Related]
37. Specific labeling of peptidoglycan precursors as a tool for bacterial cell wall studies.
van Dam V; Olrichs N; Breukink E
Chembiochem; 2009 Mar; 10(4):617-24. PubMed ID: 19173317
[TBL] [Abstract][Full Text] [Related]
38. [Antibiotics and the bacterial cell wall].
Heymer B
Aktuelle Probl Chir Orthop; 1981; 19():10-4. PubMed ID: 6112905
[No Abstract] [Full Text] [Related]
39. [Bacterial type II topoisomerases as targets for antibacterial drugs].
Pietrusiński M; Staczek P
Postepy Biochem; 2006; 52(3):271-82. PubMed ID: 17201062
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of lysine biosynthesis: an evolving antibiotic strategy.
Hutton CA; Perugini MA; Gerrard JA
Mol Biosyst; 2007 Jul; 3(7):458-65. PubMed ID: 17579770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
